Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Resmed Inc’s Chairman Emeritus, Peter C. Farrell, executed a transaction involving the sale of 2,000 shares of ResMed Common Stock at a price of $245.65 per share. This transaction, conducted under a pre-established Rule 10b5-1 plan, leaves Farrell with a total of 81,218 shares held directly in the company. Investors might keep an eye on such insider transactions as they could signal shifts in executive confidence or strategic decisions.
For further insights into AU:RMD stock, check out TipRanks’ Stock Analysis page.